/NUMD
NUMD Stock - Nu-Med Plus, Inc.
Healthcare|Medical - DevicesOTC
$0.02+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NUMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-3.25
52W High$0.14
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-12,900 | $-12,971 | $-23,040 | $-18,757 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-63,331 | $-120,526 | $-182,167 | $-839,000 | $-1,995,000 |
| Net Income | $-68,345 | $-125,526 | $-130,167 | $-830,000 | $-2,009,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.04 |
Company Overview
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NUMDBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 20, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 25, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 22, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 21, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 26, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 1, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 10, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 29, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 21, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NUMD
What is NUMD's current stock price?
Nu-Med Plus, Inc. (NUMD) is currently trading at $0.02 per share. The stock has moved +0.00% today.
What is the analyst price target for NUMD?
No analyst price targets are currently available for this stock.
What sector is Nu-Med Plus, Inc. in?
Nu-Med Plus, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is NUMD's market cap?
Nu-Med Plus, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NUMD pay dividends?
No, Nu-Med Plus, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNVIF
Binovi Technologies Corp.
$0.00
Mkt Cap: $0.0B
CRYM
Cryomass Technologies Inc.
$0.00
Mkt Cap: $0.0B
CSSI
Costas, Inc.
$0.08
Mkt Cap: $0.0B
KLYG
Kelyniam Global, Inc.
$0.12
Mkt Cap: $0.0B
MSIU
Medical Supply International USA, Inc.
$0.00
Mkt Cap: $0.0B
PLLWF
Polarean Imaging plc
$0.00
Mkt Cap: $0.0B
RHEP
Regional Health Properties, Inc.
$1.32
Mkt Cap: $0.0B
RQHTF
Reliq Health Technologies Inc.
$0.01
Mkt Cap: $0.0B
TLIS
Talis Biomedical Corporation
$2.84
Mkt Cap: $0.0B
USAQ
QHSLab, Inc.
$0.32
Mkt Cap: $0.0B
Explore stocks similar to NUMD for comparison